Morphologic expressions of urothelial carcinoma in situ: A detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion

American Journal of Surgical Pathology

Volumn 25, Issue 3, 2001, Pages 356-362

  McKenney, Jesse K ^a   Gomez, Jose A ^b   Desai, Sangeeta ^a   Lee, Min W ^b   Amin, Mahul B ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Carcinoma in situ; Histology; Microinvasion; Precursor lesions; Transitional cell carcinoma; Urinary bladder

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOMA IN SITU; DISEASE SEVERITY; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; MORPHOLOGY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA; UROTHELIUM;

CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0035110551     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200103000-00010     Document Type: Article

References (36)

1. Urothelial transitional cell carcinoma with endophytic growth pattern: A discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases
2. Intraepithelial lesions of the urothelium: An interobserver reproducibility study with proposed terminology and histotogic criteria
3. Micropapillary variant of transitional cell carcinoma of the urinary bladder: Histologic pattern resembling ovarian papillary serous carcinoma
4. A symposium of controversies in the pathology of transitional cell carcinomas of the urinary bladder, part I
5. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia
6. Natural history of urothelial dysplasia of the bladder
7. Survival of patients with carcinoma in situ of the urinary bladder
8. Cystoscopic biopsy supernate: A new cytologic approach for diagnosing urothelial carcinoma in situ
9. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
10. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder
11. Pathology of carcinoma in situ of the urinary bladder and related lesions
12. Cyrokeratin 20 as an objective marker of urothelial dysplasia
13. Carcinoma in situ of the bladder
14. Bladder cancer from a perspective of 40 years
15. Further cytologic and histologic studies of bladder lesions in workers exposed to paraaminodiphenyl: Progress report
16. Carcinoma in situ
17. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and nonneoplastic urothelium: An analysis of CK20, p53, and CD44 antigens
18. First reported cases of human bladder tumors due to new carcinogen-xenylamine
19. Intraurothelial cancer: Carcinoma in situ, Bowen's disease of the urinary system: Discussion of 30 cases
20. Pathology of epithelial tumors and carcinoma in situ of bladder
21. Current topics in the pathology of bladder cancer
22. The cellular features of developing carcinoma in murine urinary bladder
23. Developing carcinoma (dysplasia) of the urinary bladder
24. Classification of premalignant urothelial abnormalities: A Delphi study of the National Bladder Cancer Collaborative Group A
25. Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: A study of 63 patients with grade 3 lesions
26. Carcinoma in situ of the urinary bladder
27. Bladder: Risk and prognostic factors: A pathologist's perspective
28. The urothelial tract: Renal pelvis, ureter, urinary bladder, and urethra
29. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder
30. Suits & Briefs
31. Urine cytology of transitional cell neoplasms of the bladder
32. Natural history of carcinoma in situ of the urinary bladder
33. Nonpapillary intraepithelial and/or early invasive cancer arisen in the urinary bladder: Their developmental and advancing courses
34. Review of the Mayo Clinic experience with carcinoma in situ